155 related articles for article (PubMed ID: 22365771)
21. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
22. Towards more successful gene therapy clinical trials for β-thalassemia.
Drakopoulou E; Papanikolaou E; Georgomanoli M; Anagnou NP
Curr Mol Med; 2013 Sep; 13(8):1314-30. PubMed ID: 23865429
[TBL] [Abstract][Full Text] [Related]
23. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
Cavazzana-Calvo M; Payen E; Negre O; Wang G; Hehir K; Fusil F; Down J; Denaro M; Brady T; Westerman K; Cavallesco R; Gillet-Legrand B; Caccavelli L; Sgarra R; Maouche-Chrétien L; Bernaudin F; Girot R; Dorazio R; Mulder GJ; Polack A; Bank A; Soulier J; Larghero J; Kabbara N; Dalle B; Gourmel B; Socie G; Chrétien S; Cartier N; Aubourg P; Fischer A; Cornetta K; Galacteros F; Beuzard Y; Gluckman E; Bushman F; Hacein-Bey-Abina S; Leboulch P
Nature; 2010 Sep; 467(7313):318-22. PubMed ID: 20844535
[TBL] [Abstract][Full Text] [Related]
24. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].
Cartier N; Hacein-Bey-Abina S; Von Kalle C; Bougnères P; Fischer A; Cavazzana-Calvo M; Aubourg P
Bull Acad Natl Med; 2010 Feb; 194(2):255-64; discussion 264-8. PubMed ID: 21166117
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic globin gene delivery using lentiviral vectors.
Rivella S; Sadelain M
Curr Opin Mol Ther; 2002 Oct; 4(5):505-14. PubMed ID: 12435053
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy for β-thalassaemia: the continuing challenge.
Yannaki E; Emery DW; Stamatoyannopoulos G
Expert Rev Mol Med; 2010 Oct; 12():e31. PubMed ID: 20883576
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran.
Ramzi M; Nourani H; Zakernia M; Hamidian Jahromi AR
Transplant Proc; 2004 Oct; 36(8):2509-10. PubMed ID: 15561298
[TBL] [Abstract][Full Text] [Related]
28. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
[TBL] [Abstract][Full Text] [Related]
29. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
Negre O; Eggimann AV; Beuzard Y; Ribeil JA; Bourget P; Borwornpinyo S; Hongeng S; Hacein-Bey S; Cavazzana M; Leboulch P; Payen E
Hum Gene Ther; 2016 Feb; 27(2):148-65. PubMed ID: 26886832
[TBL] [Abstract][Full Text] [Related]
30. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
31. Update on gene therapy for hemoglobin disorders.
Persons DA
Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
[TBL] [Abstract][Full Text] [Related]
32. In vivo gene delivery into hCD34+ cells in a humanized mouse model.
Frecha C; Fusil F; Cosset FL; Verhoeyen E
Methods Mol Biol; 2011; 737():367-90. PubMed ID: 21590405
[TBL] [Abstract][Full Text] [Related]
33. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
Payen E; Leboulch P
Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
[TBL] [Abstract][Full Text] [Related]
34. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.
Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836
[TBL] [Abstract][Full Text] [Related]
36. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
[TBL] [Abstract][Full Text] [Related]
37. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic peripheral blood stem cell transplantation in beta-thalassemia.
Fang J; Huang S; Chen C; Zhou D; Wu Y; Bao R
Pediatr Hematol Oncol; 2002; 19(7):453-8. PubMed ID: 12217190
[TBL] [Abstract][Full Text] [Related]
39. Gene Therapy and Genome Editing.
Boulad F; Mansilla-Soto J; Cabriolu A; Rivière I; Sadelain M
Hematol Oncol Clin North Am; 2018 Apr; 32(2):329-342. PubMed ID: 29458735
[TBL] [Abstract][Full Text] [Related]
40. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
